BR9803497A - Compostos, composições farmacêuticas, e processos para preparar os compostos e as composições e para tratar distúrbio do sistema nervoso central. - Google Patents

Compostos, composições farmacêuticas, e processos para preparar os compostos e as composições e para tratar distúrbio do sistema nervoso central.

Info

Publication number
BR9803497A
BR9803497A BR9803497-9A BR9803497A BR9803497A BR 9803497 A BR9803497 A BR 9803497A BR 9803497 A BR9803497 A BR 9803497A BR 9803497 A BR9803497 A BR 9803497A
Authority
BR
Brazil
Prior art keywords
compounds
group
compositions
alkyl
processes
Prior art date
Application number
BR9803497-9A
Other languages
English (en)
Inventor
Martinus T M Tulp
Stephen K Long
Hartog Jacobus A J Den
Roelof W Feenstra
Cornelis G Kruse
Original Assignee
Duphar Int Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Duphar Int Res filed Critical Duphar Int Res
Publication of BR9803497A publication Critical patent/BR9803497A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)

Abstract

"COMPOSTOS, COMPOSIçõES FARMACêUTICAS, E PROCESSOS PARA PREPARAR OS COMPOSTOS E AS COMPOSIçõES E PARA TRATAR DISTúRBIOS DO SISTEMA NERVOSO CENTRAL". A invenção refere-se a um grupo de novos compostos de piperazina e piperidina, tendo interessantes propriedades farmacológicas. Descobriu-se que os compostos de fórmula (a) em que - A representa um grupo heterocíclico de 5-7 átomos no anel, em que 1-3 heteroátomos do grupo O, N e S estão presentes, - R1 é hidrogênio ou fluoro, - R2 é alquila C1-4, alcóxi-C1-4 ou um grupo oxo e p é 0, 1 ou - Z representa carbono ou nitrogênio e a linha pontilhada é uma única ligação quando Z for nitrogênio e uma única ou dupla ligação quando Z for carbono, - R3 e R~ 4~ são, independentemente, hidrogênio ou alquila C1-4. - n tem o valor 1 ou 2, - R^ 5^ é 2-piridila, 3-piridila ou 4-piridila substituída na posição-meta com respeito à ponte metileno com um grupo Y e, opcionalmente, substituída com (R~ 6~)~ q~, - Y é fenila, furanila ou tienila, grupos estes podendo ser substituídos por 1-3 substituintes do grupo hidróxi, halogênio, CF~ 3~, alcóxi-C1-4, alquila-C1-4. ciano, aminocarbonila, mono ou di-C1-4-alquilaminocarbonila, - R6 é halogênio, hidróxi, alcóxi C1-4 ou alquila C1-4 e q é 0, 1, 2 ou 3 e seus sais.
BR9803497-9A 1997-09-24 1998-09-21 Compostos, composições farmacêuticas, e processos para preparar os compostos e as composições e para tratar distúrbio do sistema nervoso central. BR9803497A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97202950 1997-09-24

Publications (1)

Publication Number Publication Date
BR9803497A true BR9803497A (pt) 2000-05-02

Family

ID=8228755

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9803497-9A BR9803497A (pt) 1997-09-24 1998-09-21 Compostos, composições farmacêuticas, e processos para preparar os compostos e as composições e para tratar distúrbio do sistema nervoso central.

Country Status (31)

Country Link
US (2) US6090812A (pt)
EP (1) EP0908458B1 (pt)
JP (1) JP4191826B2 (pt)
KR (1) KR100632188B1 (pt)
CN (1) CN1093857C (pt)
AR (1) AR017127A1 (pt)
AT (1) ATE316529T1 (pt)
AU (1) AU733526B2 (pt)
BR (1) BR9803497A (pt)
CA (1) CA2247734C (pt)
CY (1) CY1107494T1 (pt)
CZ (1) CZ296741B6 (pt)
DE (1) DE69833297T2 (pt)
DK (1) DK0908458T3 (pt)
DZ (1) DZ2613A1 (pt)
ES (1) ES2255127T3 (pt)
HK (1) HK1018272A1 (pt)
HU (1) HU227422B1 (pt)
ID (1) ID20895A (pt)
IL (1) IL126295A (pt)
NO (1) NO312835B1 (pt)
NZ (1) NZ331984A (pt)
PL (1) PL190622B1 (pt)
PT (1) PT908458E (pt)
RU (1) RU2197488C2 (pt)
SI (1) SI0908458T1 (pt)
SK (1) SK285205B6 (pt)
TR (1) TR199801866A1 (pt)
TW (1) TW530054B (pt)
UA (1) UA66756C2 (pt)
ZA (1) ZA988749B (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6200994B1 (en) 1999-01-07 2001-03-13 American Home Products Corp 1,4-Disubstituted cyclohexane derivatives for the treatment of depression
WO2000040579A1 (en) * 1999-01-07 2000-07-13 American Home Products Corporation New 1,4-disubstituted cyclohexane derivatives for the treatment of depression
DE10005150A1 (de) * 2000-02-07 2001-08-09 Merck Patent Gmbh Verfahren zur Herstellung von 5-Arylnicotinaldehyden
DE10115922A1 (de) * 2001-03-30 2002-10-10 Bayer Ag Cyclisch substituierte 2-Thio-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung
EP1408976B3 (en) 2001-07-20 2010-08-25 Psychogenics Inc. Treatment for attention-deficit hyperactivity disorder
US7435738B2 (en) 2003-08-18 2008-10-14 Solvay Pharmaceuticals, Inc. Stable crystalline form of bifeprunox mesylate (7-[4-([1,1′-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate)
US7405216B2 (en) 2004-08-18 2008-07-29 Solvay Pharmaceuticals, B.V. Stable crystalline form of bifeprunox mesylate (7-[4-([1,1′-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate)
US7423040B2 (en) 2005-02-18 2008-09-09 Irene Eijgendaal Stable crystalline form of bifeprunox mesylate, dosage forms thereof and methods for using same
US7964604B2 (en) 2005-02-18 2011-06-21 Solvay Pharmaceuticals B.V. Bifeprunox mesylate maintenance dose compositions and methods for using the same
US20070275977A1 (en) * 2006-05-02 2007-11-29 Van Aar Marcel P N-oxides of pyridylmethyl -piperazine and -piperidine derivatives
AU2007247251B2 (en) 2006-05-02 2011-11-03 Solvay Pharmaceuticals B.V. N-oxides of pyridylmethylpiperazine and -piperidine derivatives
US8106056B2 (en) 2006-06-16 2012-01-31 Solvay Pharmaceuticals B.V. Combination preparations comprising bifeprunox and a dopamine agonist
US7786126B2 (en) 2006-06-16 2010-08-31 Solvay Pharmaceuticals B.V. Combination preparations comprising SLV308 and a dopamine agonist
WO2011088838A1 (en) 2010-01-25 2011-07-28 H. Lundbeck A/S Novel 6,6a,7,8,9,10-hexahydro-4h-4,8,10a-triaza-acephenanthrylene derivatives as dopamine d2 ligands
US8877778B2 (en) 2010-12-15 2014-11-04 Hoffmann-La Roche Inc. Benzofurane compounds
US8921397B2 (en) 2011-05-04 2014-12-30 Hoffmann-La Roche Inc. Benzofurane-piperidine compounds
TWI806385B (zh) 2016-07-20 2023-06-21 瑞士商諾華公司 胺基吡啶衍生物及其作為選擇性alk-2抑制劑之用途
KR101665971B1 (ko) 2016-08-10 2016-10-13 (주)글로벌 로보틱스 차량용 발포패드 부착장치
CN115038443A (zh) 2019-11-22 2022-09-09 因西特公司 包含alk2抑制剂和jak2抑制剂的组合疗法
IL298767A (en) 2020-06-16 2023-02-01 Incyte Corp ALK2 inhibitors for the treatment of anemia

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0190472B1 (en) * 1984-12-21 1989-07-12 Duphar International Research B.V New pharmaceutical compositions having anti-psychotic properties
DE3586794T2 (de) 1984-12-21 1993-05-27 Duphar Int Res Arzneimittel mit psychotroper wirkung.
PH22783A (en) * 1986-02-27 1988-12-12 Duphar Int Res New aryl-substituted (n-piperidinyl)methyl-and (n-piperazinyl)methylazoles and pharmaceutical compositions containing the same
EP0508347A1 (en) 1991-04-10 1992-10-14 Hoechst Aktiengesellschaft 5,7-Dihydroxy-2-methyl-8-[4-(3-hydroxy-1-(1-propyl)) piperidinyl]-4H-1-benzopyran-4-one, its preparation and its use
IE914218A1 (en) * 1991-09-11 1993-03-24 Mcneilab Inc Novel 4-arylpiperazines and 4-arylpiperidines
JPH05262765A (ja) 1992-03-18 1993-10-12 Sumitomo Chem Co Ltd ベンゾフラン誘導体およびそれを有効成分とする除草剤
FR2692264B1 (fr) 1992-06-12 1994-08-05 Adir Nouvelles piperazines 1,4-disubstituees, leur procede de preparation et les compositions pharmaceutiques les contenant.
US5332732A (en) * 1992-09-11 1994-07-26 Mcneilab, Inc. Thiophene and pyridine antipsychotic agents
US5436246A (en) * 1992-09-17 1995-07-25 Merrell Dow Pharmaceuticals Inc. Serotonin receptor agents
RU2118322C1 (ru) * 1993-07-05 1998-08-27 Дюфар Интернэшнл Рисерч Б.В. 2,3-дигидро-1,4-бензодиокси-5-ил-пиперазиновые производные или их соли
GB9314758D0 (en) * 1993-07-16 1993-08-25 Wyeth John & Brother Ltd Heterocyclic derivatives
EP0650964A1 (en) 1993-11-02 1995-05-03 Duphar International Research B.V 1 2H-1-benzopyran-2-one-8-yl -piperazine derivatives
DE4425146A1 (de) * 1994-07-15 1996-01-18 Basf Ag Verwendung heterocyclischer Verbindungen
US5607936A (en) * 1994-09-30 1997-03-04 Merck & Co., Inc. Substituted aryl piperazines as neurokinin antagonists
US6114334A (en) * 1995-07-13 2000-09-05 Knoll Aktiengesellschaft Piperazine derivatives as therapeutic agents
PL189256B1 (pl) * 1996-03-29 2005-07-29 Duphar Int Res Związki piperazyny i piperydyny, sposób ich wytwarzania, kompozycja farmaceutyczna zawierająca te związki, zastosowanie tych związków do wytwarzania leków
DE19637237A1 (de) 1996-09-13 1998-03-19 Merck Patent Gmbh Piperazin-Derivate

Also Published As

Publication number Publication date
NO984380L (no) 1999-03-25
IL126295A (en) 2003-02-12
KR100632188B1 (ko) 2007-04-25
CY1107494T1 (el) 2013-03-13
KR19990029982A (ko) 1999-04-26
PL190622B1 (pl) 2005-12-30
DZ2613A1 (fr) 2003-03-01
JP4191826B2 (ja) 2008-12-03
SK285205B6 (sk) 2006-08-03
AU8607998A (en) 1999-04-15
AR017127A1 (es) 2001-08-22
TR199801866A1 (xx) 1999-04-21
ATE316529T1 (de) 2006-02-15
ES2255127T3 (es) 2006-06-16
HK1018272A1 (en) 1999-12-17
TW530054B (en) 2003-05-01
CZ303098A3 (cs) 1999-04-14
HUP9802129A1 (hu) 2000-03-28
HU9802129D0 (en) 1998-11-30
DE69833297D1 (de) 2006-04-13
NZ331984A (en) 2000-02-28
IL126295A0 (en) 1999-05-09
PT908458E (pt) 2006-05-31
ZA988749B (en) 1999-03-26
HU227422B1 (en) 2011-05-30
CZ296741B6 (cs) 2006-06-14
CN1093857C (zh) 2002-11-06
EP0908458A1 (en) 1999-04-14
SK129498A3 (en) 1999-04-13
EP0908458B1 (en) 2006-01-25
CA2247734C (en) 2007-08-07
JPH11302279A (ja) 1999-11-02
AU733526B2 (en) 2001-05-17
CN1220265A (zh) 1999-06-23
USRE41425E1 (en) 2010-07-06
NO984380D0 (no) 1998-09-21
US6090812A (en) 2000-07-18
NO312835B1 (no) 2002-07-08
DE69833297T2 (de) 2006-07-20
PL328754A1 (en) 1999-03-29
DK0908458T3 (da) 2006-06-06
SI0908458T1 (sl) 2006-06-30
CA2247734A1 (en) 1999-03-24
RU2197488C2 (ru) 2003-01-27
ID20895A (id) 1999-03-25
UA66756C2 (uk) 2004-06-15

Similar Documents

Publication Publication Date Title
BR9803497A (pt) Compostos, composições farmacêuticas, e processos para preparar os compostos e as composições e para tratar distúrbio do sistema nervoso central.
DE69730490T2 (de) Aminoheterocyclische verbindungen als antithrombotisches oder antikoagulierendes mittel
BRPI9811688A (pt) benzamidas bicíclicas gastrocinéticas de derivados de piperidina 3- ou 4- substituídos com 4-aminometil), processo para preparação das mesmas, composições farmacêuticas compreendendo as mesmas e processo para preparação das referidas composições.
BR0109457A (pt) Composto, composição farmacêutica,método de preparação de composições farmacêuticas, processo para prepapação de compostos, e, métodos de tratamento de distúrbios psiquiátricos, de distúrbios gastrointestinais e de distúrbios cardiovasculares
BRPI0615111B8 (pt) composto, composição farmacêutica, e, uso do composto
BR0009952A (pt) Composto, pró-droga, processo para produzir um composto, composição farmacêutica, método para antagonizar um receptor de adenosina a3, para inibir a p38 map quinase e a produção de tnf-alfa e para prevenir ou tratar doenças, e uso de um composto
CA2850644A1 (en) Substituted 4-phenyl-pyridines for the treatment of nk-1 receptor related diseases
WO2003080580A3 (en) Quinoline derivatives and their use as 5-ht6 ligands
PT1492785E (pt) Derivados de 2-hidroxi-3-heteroarilindole como inibidores de gsk3
BR9708389A (pt) Compostos de piperazina e piperidina, composições farmacêuticas e processo para preparação dos compostos e das composições farmacêuticas e para tratamentro de distúrbios do sistema nervoso central.
NO20051826L (no) Heterosyklisk substituerte piperaziner for behandling av schizofreni
BRPI0918268A2 (pt) inibores de cinase e métodos para uso dos mesmos
BRPI0617880B8 (pt) composto derivado de piridina substituído por heterociclo, composição farmacêutica, medicamento e agente antifúngico que compreende o dito composto e uso do mesmo para prevenir e/ou tratar infecção fúngica
BR9914379A (pt) Composto, processo para a preparação de um composto, método para a produção de um efeito antibacteriano em um animal de sangue quente, uso de um composto, e, composição farmacêutica
NO990551L (no) Piperidin- og piperazinderivater, og deres anvendelse som muskarine antagonister
DE3836676A1 (de) Die verwendung von 4h-1-benzopyran-4-on-derivaten, neue 4h-1-benzopyran-4-on-derivate und diese enthaltende arzneimittel
CA2971357A1 (en) Amido thiadiazole derivatives as nadph oxidase inhibitors
BR0013498A (pt) Composto, método para a preparação do mesmo, composição farmacêutica, e, métodos para a preparação da mesma e para o tratamento de distúrbios do snc
ATE440096T1 (de) Substituierte thiazolderivate mit 3- pyridylgruppen, verfahren zu deren herstellung und deren verwendung
BR112012007069A2 (pt) derivado de fenol
BR0213646A (pt) Método, compostos e composição para controle de pragas invertebradas
PT736525E (pt) Benzonitrilos e fluoretos como agonistas e antagonistas de 5-ht
HUT63143A (en) Process for producing diamine derivatives and pharmaceutical compositions comprising such active ingredient
AR121744A1 (es) MODULADORES DE a 1-ANTITRIPSINA
TW360650B (en) Pyridin-2-ylmethyloxy-pyridin-5-ylcarbamoyl-indoline derivatives, a process for the preparation thereof, and a pharmaceutical composition comprising them

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFERIMENTO DO PRESENTE PEDIDO, UMA VEZ QUE INCIDE NOS ARTIGOS 8O, 10 ( VIII ),11, 13, 24 E 25 DA LPI

B12B Appeal against refusal [chapter 12.2 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B08L Patent application lapsed because of non payment of annual fee [chapter 8.12 patent gazette]

Free format text: ARQUIVAMENTO DEFINITIVO

B08I Publication cancelled [chapter 8.9 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 8.12 NA RPI NO 2285 DE 21/10/2014 POR TER SIDO INDEVIDA.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 14A,15A,16A,17A,18A,19A,20A,21A E 22A ANUIDADES

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2611 DE 19/01/2021.